13 Warde P, Specht L, Horwich A et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J. Clin. Oncol. 2002; 20: 4448–52.
14 Aparicio J, Germa JR, Garcia del Muro X et al. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study. J. Clin. Oncol. 2005; 23: 8717–23.
15 Zagars GK, Ballo MT, Lee AK, Strom SS. Mortality after cure of testicular seminoma. J. Clin. Oncol. 2004; 22: 640–7.
16 Reiter WJ, Brodowicz T, Alavi S et al. Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma. J. Clin. Oncol. 2001; 19: 101–4.
1 Martin JM, Panzarella T, Zwahlen DR, Chung P, Warde P. Evidence-based guidelines for following stage 1 seminoma. Cancer 2007; 109: 2248–56.
17 Aparicio J, Garcia del Muro X, Maroto P et al. Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. Ann. Oncol. 2003; 14: 867–72.
2 Classen J, Souchon R, Hehr T, Bamberg M. Treatment of early stage testicular seminoma. J. Cancer Res. Clin. Oncol. 2001; 127: 475–81.
18 Powles T, Robinson D, Shamash J et al. The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann. Oncol. 2008; 19: 443–7.
3 Skliarenko J, Vesprini D, Warde P. Stage I seminoma: what should a practicing uro-oncologist do in 2009? Int. J. Urol. 2009; 16: 544–51.
19 Peckham MJ, Brada M. Surveillance following orchidectomy for stage I testicular cancer. Int. J. Androl. 1987; 10: 247–54.
4 Nakata S, Ohtake N, Kubota Y et al. Incidence of urogenital cancers in Gunma Prefecture, Japan: a 10-year summary. Int. J. Urol. 1998; 5: 364–9.
20 Dalal PU, Sohaib SA, Huddart R. Imaging of testicular germ cell tumours. Cancer Imaging 2006; 6: 124–34.
5 Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J. Urol. 2003; 170: 5–11.
21 Kakehi Y, Kamoto T, Kawakita M, Ogawa O. Follow-up of clinical stage I testicular cancer patients: cost and risk benefit considerations. Int. J. Urol. 2002; 9: 154–60; discussion 160–1.
6 Miki T, Nonomura N, Saiki S, Kotake T. Long-term results of adjuvant irradiation or surveillance in stage I testicular seminoma. Int. J. Urol. 1998; 5: 357–60.
22 Albers P, Albrecht W, Albaga F et al. Guidelines on Testicular Cancer. [Cited 27 April 2009.] Available from URL: 
7 Sato A, Ohigashi T, Oya M et al. Clinicopathological features predicting nodal metastasis of testicular seminoma: results from 100 cases in a single institute. Urol. Int. 2006; 77: 64–8.
8 Yoshida T, Kakimoto K, Takezawa K et al. Surveillance following orchiectomy for stage I testicular seminoma: long-term outcome. Int. J. Urol. 2009; 16: 756–9.